Albert Bourla, AP Images
Pfizer reveals delays across the board for its clinical gene therapy programs
At JP Morgan 2020, a year after taking the reins at Pfizer, Albert Bourla claimed the company was poised to become a leader in gene …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
